Rare and Neglected Diseases

  • ChemPubSoc Europe Logo
  • Author: Scott Williams/ChemViews
  • Published Date: 07 February 2011
  • Source / Publisher: ChemMedChem/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Rare and Neglected Diseases

Related Societies

Generally speaking, rare and neglected diseases (RND) are those for which the costs of developing a drug treatment cannot be recovered. A given disease under the RND classification is, therefore, quite likely to go undertreated, or largely untreated altogether.


The “big hitters” in neglected diseases are tuberculosis (TB), caused by pathogenic bacteria, malaria, human African trypanosomiasis (sleeping sickness), Chagas disease and visceral leishmaniasis, all of which are caused by parasitic microbes. TB is the world's leading cause of death from a single infectious organism, killing two million people each year.


Paying greater attention to RND is clearly important for humanitarian, social, and economic reasons. Many RND are anything but "rare", as they affect millions worldwide, and an ideal goal would be to do away with the "N" in RND. With that in mind, the February issue of ChemMedChem is dedicated to medicinal chemistry research into RND.


Two of ChemMedChem's board members, Professors Maurizio Botta, University of Siena, Italy, and Alan Kozikowski, University of Illinois, Chicago, USA, introduce the issue with their editorial outlining some of important diseases that are classified as RND, to the surprise of many people.

Image: (c) Wiley-VCH


► Also see:

  • News: A Drug Pipeline Going Dry
    The number of effective anti-tuberculosis (TB) drugs continues to dwindle; can we find new agents for treating drug-resistant TB?

Article Views: 4440

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH